Literature DB >> 9671455

Interplay of positive and negative regulators in transcription initiation by RNA polymerase II holoenzyme.

T I Lee1, J J Wyrick, S S Koh, E G Jennings, E L Gadbois, R A Young.   

Abstract

Activation of protein-encoding genes involves recruitment of an RNA polymerase II holoenzyme to promoters. Since the Srb4 subunit of the holoenzyme is essential for expression of most class II genes and is a target of at least one transcriptional activator, we reasoned that suppressors of a temperature-sensitive mutation in Srb4 would identify other factors generally involved in regulation of gene expression. We report here that MED6 and SRB6, both of which encode essential components of the holoenzyme, are among the dominant suppressors and that the products of these genes interact physically with Srb4. The recessive suppressors include NCB1 (BUR6), NCB2, NOT1, NOT3, NOT5, and CAF1, which encode subunits of NC2 and the Not complex. NC2 and Not proteins are general negative regulators which interact with TATA box binding protein (TBP). Taken together, these results suggest that transcription initiation involves a dynamic balance between activation mediated by specific components of the holoenzyme and repression by multiple TBP-associated regulators.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671455      PMCID: PMC109031          DOI: 10.1128/MCB.18.8.4455

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

Review 1.  Histone function in transcription.

Authors:  M Grunstein
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Functional differences between yeast and human TFIID are localized to the highly conserved region.

Authors:  B P Cormack; M Strubin; A S Ponticelli; K Struhl
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

3.  Nucleosome loss activates yeast downstream promoters in vivo.

Authors:  M Han; M Grunstein
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

4.  Mutations in RNA polymerase II enhance or suppress mutations in GAL4.

Authors:  L A Allison; C J Ingles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  5-Fluoroorotic acid as a selective agent in yeast molecular genetics.

Authors:  J D Boeke; J Trueheart; G Natsoulis; G R Fink
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Genetic applications of yeast transformation with linear and gapped plasmids.

Authors:  T L Orr-Weaver; J W Szostak; R J Rothstein
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  RNA polymerase II C-terminal repeat influences response to transcriptional enhancer signals.

Authors:  C Scafe; D Chao; J Lopes; J P Hirsch; S Henry; R A Young
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

8.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

9.  High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier.

Authors:  R H Schiestl; R D Gietz
Journal:  Curr Genet       Date:  1989-12       Impact factor: 3.886

10.  Functional antagonism between RNA polymerase II holoenzyme and global negative regulator NC2 in vivo.

Authors:  E L Gadbois; D M Chao; J C Reese; M R Green; R A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  48 in total

1.  Drosophila homologs of transcriptional mediator complex subunits are required for adult cell and segment identity specification.

Authors:  M Boube; C Faucher; L Joulia; D L Cribbs; H M Bourbon
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

2.  Identification of a ubiquitin-protein ligase subunit within the CCR4-NOT transcription repressor complex.

Authors:  Thomas K Albert; Hiroyuki Hanzawa; Yvonne I A Legtenberg; Marjolein J de Ruwe; Fiona A J van den Heuvel; Martine A Collart; Rolf Boelens; H Th Marc Timmers
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

3.  The NC2 alpha and beta subunits play different roles in vivo.

Authors:  Sandrine Creton; Jesper Q Svejstrup; Martine A Collart
Journal:  Genes Dev       Date:  2002-12-15       Impact factor: 11.361

4.  Crystal structure of the human CNOT6L nuclease domain reveals strict poly(A) substrate specificity.

Authors:  Hui Wang; Masahiro Morita; Xiuna Yang; Toru Suzuki; Wen Yang; Jiao Wang; Kentaro Ito; Quan Wang; Cong Zhao; Mark Bartlam; Tadashi Yamamoto; Zihe Rao
Journal:  EMBO J       Date:  2010-07-13       Impact factor: 11.598

Review 5.  The structural basis for deadenylation by the CCR4-NOT complex.

Authors:  Mark Bartlam; Tadashi Yamamoto
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

6.  Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits.

Authors:  T K Albert; M Lemaire; N L van Berkum; R Gentz; M A Collart; H T Timmers
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 7.  The mediator of RNA polymerase II.

Authors:  Erik Blazek; Gerhard Mittler; Michael Meisterernst
Journal:  Chromosoma       Date:  2005-02-03       Impact factor: 4.316

8.  Activator-specific requirement of yeast mediator proteins for RNA polymerase II transcriptional activation.

Authors:  S J Han; Y C Lee; B S Gim; G H Ryu; S J Park; W S Lane; Y J Kim
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

9.  Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB.

Authors:  J A Ranish; N Yudkovsky; S Hahn
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

10.  Direct stimulation of transcription by negative cofactor 2 (NC2) through TATA-binding protein (TBP).

Authors:  Yong Cang; Gregory Prelich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.